LJT: Port & Catheter, Implanted, Subcutaneous, Intravascular

Product code LJT, “Port & Catheter, Implanted, Subcutaneous, Intravascular” in FDA's classification database, is a Class II device type under 21 CFR 880.5965 (subcutaneous, implanted, intravascular infusion port and catheter), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 288 clearances under LJT, 30 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LJT
Regulation
21 CFR 880.5965
Class
II
Panel
General Hospital
Clearances
288
Most recent
Jun 17, 2026
Median review, last 2 years
71 days
Third-party review
Not eligible
Implant
Yes

What it covers

A subcutaneous, implanted, intravascular infusion port and catheter is a device that consists of a subcutaneous, implanted reservoir that connects to a long-term intravascular catheter. The device allows for repeated access to the vascular system for the infusion of fluids and medications and the sampling of blood. The device consists of a portal body with a resealable septum and outlet made of metal, plastic, or combination of these materials and a long-term intravascular catheter is either preattached to the port or attached to the port at the time of device placement. The device is available in various profiles and sizes and can be of a single or multiple lumen design.

The identification in 21 CFR 880.5965, subcutaneous, implanted, intravascular infusion port and catheter. FDA gives LJT no definition of its own, so the regulation’s describes it.

FDA flags LJT devices as implants.

Recent clearances

510(k)DeviceApplicantDecisionType
K260916FLEXI-PORT™ Power Injectable Implantable PortPortal Access, Inc.Jun 17, 2026Traditional
K252478Vaccess™ CT Low-Profile Power-Injectable Implantable Port; Vaccess™ CT Power-Injectable Implantable Port; PowerPort™ duo M.R.I. ™ Implantable PortBard Access Systems, Inc.Sep 5, 2025Special
K251253PowerPort™ isp Implantable Port; PowerPort™ Slim Implantable Port; PowerPort™ M.R.I. ™ Implantable Port; PowerPort™ M.R.I.™ isp Implantable PortBard Access Systems, Inc.Jun 18, 2025Special
K242328PowerPort™ ClearVUE™ Slim Implantable Ports and PowerPort™ ClearVUE™ Slim Implantable PortsBard Access Systems, Inc.Oct 31, 2024Special
K232737PowerPort™ ClearVUE™ Slim ECG Enabled Implantable Port; PowerPort™ ClearVUE™ isp ECG Enabled Implantable Port; PowerPort™ isp M.R.I.™ ECG Enabled Implantable Port; PowerPort™ Slim ECG Enabled Implantable PortBard Peripheral Vascular, Inc.Dec 8, 2023Special
K190559SmartPort+ Implantable Ports, SmartPort Plastic Implantable PortsAngioDynamics, Inc.May 22, 2020Traditional
K181446Bard Power-Injectable Implantable Ports (PowerPorts®)C.R. Bard, Inc.Jul 8, 2019Traditional
K151239NMI DUAL PORT IINavilyst Medical, Inc.Jun 6, 2016Traditional
K153359BardPort®, SlimPort®, and X-Port® Implanted PortsC.R. Bard, Inc.May 20, 2016Special
K153238Dignity Dual PortMedcomp ( Medical Components)Mar 15, 2016Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 288 with a free account)

Clearances by year

30 LJT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)190
2025243
2024186
2023192
20201444
20191402
20163182
20154164
20142113
20137150
20122143
20115144

Who submits

15 applicants cleared a LJT device since 2011. 97% of the clearances went to applicants in United States, then France (3%). By type: Traditional 60%, Special 33% and Abbreviated 7%.

ApplicantClearances since 2011
C.R. Bard, Inc.5
Navilyst Medical, Inc.4
Bard Access Systems, Inc.3
Medcomp ( Medical Components)3
Cook Incorporated2
Medical Components, Inc.2
Norfolk Medical Products, Inc.2
Stealth Therapeutics, Incorporated2

How FDA classifies it

Class II (special controls) Guidance Document: “Guidance on 510(k) Submissions for Implanted Infusion Ports,” FDA October 1990.

From 21 CFR 880.5965. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 880.5965 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LJT clearances declared.

Ask about LJT

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LJT

What is FDA product code LJT?

Product code LJT, “Port & Catheter, Implanted, Subcutaneous, Intravascular” in FDA's classification database, is a Class II device type under 21 CFR 880.5965 (subcutaneous, implanted, intravascular infusion port and catheter), reviewed by FDA's General Hospital panel. FDA's 510(k) database lists 288 clearances under LJT, 30 of them since 2011.

How many 510(k) clearances are there under LJT?

FDA’s 510(k) database listed 288 clearances under LJT as of Oct 29, 2026, 30 of them decided since 2011; the most recent decision was Jun 17, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a LJT 510(k)?

For the 4 LJT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 71 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LJT clearances?

Since 2011: C.R. Bard, Inc. (5), Navilyst Medical, Inc. (4), Bard Access Systems, Inc. (3), Medcomp ( Medical Components) (3) and Cook Incorporated (2). 15 applicants have cleared a LJT device in that time.

Sources

  1. FDA product classification: LJT · Product Classification database
  2. 21 CFR 880.5965: Subcutaneous, implanted, intravascular infusion port and catheter · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LJT · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LJTGet an email when FDA clears, recalls or publishes guidance for LJT devices.

Know what FDA already cleared.